CUSIP 528872302COM NEWLXRXQ4 2025
23 filings · latest Feb 2, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Artal Group S.A. | 136.18M | $156.61M |
| 2 | Siren, L.L.C. | 38.92M | $44.76M |
| 3 | Fmr LLC | 37.83M | $43.51M |
| 4 | Vanguard Group Inc | 9.61M | $11.05M |
| 5 | Millennium Management LLC | 4.82M | $5.54M |
| 6 | Blackrock, Inc. | 3.19M | $3.67M |
| 7 | Ubs Group AG | 3.01M | $3.46M |
| 8 | Sessa Capital Im, L.P. | 3.00M | $3.45M |
| 9 | Geode Capital Management, LLC |
| 4 | Dec 9, 2024 | Invus, L.P. | 13D/A | 10.8% | 38.92M | SEC |
| 5 | Nov 14, 2024 | Biotechnology Value Fund L P | 13G/A | — | — | SEC |
| 6 | Nov 12, 2024 | Fmr LLC | 13G/A | 13.8% | — | SEC |
| 7 | Jul 29, 2024 | Invus, L.P. | 13D/A | 10.8% | 38.92M | SEC |
| 8 | Jul 10, 2024 | Fmr LLC | 13G | 10.7% | — | SEC |
| 9 | May 14, 2024 | Invus, L.P. | 13D/A | 10.8% | 38.92M | SEC |
| 10 | Mar 13, 2024 | Invus, L.P. | 13D/A | 15.8% | 38.92M | SEC |
See the full Schedule 13D/13G history for Lexicon Pharmaceuticals Inc.
Unlock full history| 2.50M |
| $2.88M |
| 10 | Cibc Private Wealth Group LLC | 1.95M | $2.24M |